A Phase 1–2 Dose-Escalating Study Evaluating the Safety and Tolerability of Istaroxime and Specific Effects on Electrocardiographic and Hemodynamic Parameters in Patients with Chronic Heart Failure with Reduced Systolic Function
Jalal K. Ghali, William B. Smith, Guillermo Torre-Amione, William Haynos, Barry K. Rayburn, Antonino Amato, Dan Zhang, Doug Cowart, Giovanni Valentini, Paolo Carminati, Mihai GheorghiadeVolume:
99
Year:
2007
Language:
english
Pages:
1
DOI:
10.1016/j.amjcard.2006.09.006
File:
PDF, 963 KB
english, 2007